146 related articles for article (PubMed ID: 8210771)
1. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
Góngora-Biachi RA; González-Martínez P; Puerto FI; Bastarrachea-Ortíz J; Yamaguchi K; Nishimura Y; Takatsuki K
Rev Invest Clin; 1993; 45(3):281-2. PubMed ID: 8210771
[No Abstract] [Full Text] [Related]
2. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
[TBL] [Abstract][Full Text] [Related]
3. Worldwide distribution of HTLV.
Tajima K
Jpn J Cancer Res; 1998 Jan; 89(1):inside front cover. PubMed ID: 9510466
[No Abstract] [Full Text] [Related]
4. [Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection].
Soriano V; Calderón E; Cilla G; Aguilera A; Merino F; Gutiérrez M
Med Clin (Barc); 1993 Apr; 100(13):492-6. PubMed ID: 8479231
[TBL] [Abstract][Full Text] [Related]
5. HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
Pinheiro SR; Carneiro-Proietti AB; Lima-Martins MV; Proietti FA; Pereira AA; Oréfice F
Rev Soc Bras Med Trop; 1996; 29(4):383-4. PubMed ID: 8768591
[No Abstract] [Full Text] [Related]
6. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
7. HTLV-I/II antibodies among three different Indian groups from Paraguay.
de Cabral MB; Vera ME; Samudio M; Arias AR; Cabello A; Moreno R; Zapiola I; Bouzas MB; Muchinik G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):548-9. PubMed ID: 9859972
[No Abstract] [Full Text] [Related]
8. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
[No Abstract] [Full Text] [Related]
9. Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon.
Machuca A; Wood O; Lee S; Daniel S; Rios M; Wolfe ND; Carr JK; Eitel MN; Tamoufe U; Torimiro JN; Burke D; Hewlett IK
Clin Infect Dis; 2005 Jun; 40(11):1673-6. PubMed ID: 15889367
[TBL] [Abstract][Full Text] [Related]
10. HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs.
Del Mistro A; Chotard J; Hall AJ; Fortuin M; Whittle H; De Rossi A; Chieco-Bianchi L
AIDS Res Hum Retroviruses; 1994 May; 10(5):617-20. PubMed ID: 7917523
[No Abstract] [Full Text] [Related]
11. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
[TBL] [Abstract][Full Text] [Related]
12. HTLV-II and a new endemic area for HTLV-I in Brazil.
Moreira Júnior ED; Harrington Júnior W; Ribeiro TT; Melo A; Brites C; Badaró R; Swanson P; Lee H
Rev Soc Bras Med Trop; 1992; 25(2):141-3. PubMed ID: 1308940
[No Abstract] [Full Text] [Related]
13. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
[TBL] [Abstract][Full Text] [Related]
14. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
Olaleye OD; Ekweozor CC
Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
[TBL] [Abstract][Full Text] [Related]
15. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
17. [Lymphotropic viruses type I and II in pregnant women in Yucatán].
Góngora-Biachi RA; González-Martínez P; Castro-Sansores C; Vivas-Rosel ML; Gasque-López F; Garrido-Hadad E
Rev Invest Clin; 1996; 48(5):383-4. PubMed ID: 9005516
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China.
Cao F; Ji Y; Huang R; Lin S
Vox Sang; 1998; 75(2):154. PubMed ID: 9784671
[No Abstract] [Full Text] [Related]
19. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
[TBL] [Abstract][Full Text] [Related]
20. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
Vranckx R; Coenjaert A; Muylle L
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
